pocketful logo
ANG Lifesciences India Ltd logo

ANG Lifesciences India Ltd

NSE: BSE: 540694

₹26.71

(10.10%)

Tue, 21 Apr 2026, 06:35 pm

ANG Lifesciences India Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    34.68

  • Net Profit

    -12.41

  • P/B

    0.50

  • Sector P/E

    32.46

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.85

  • ROCE (Industry)

    13.28

  • RONW (Industry)

    12.53

  • ROE

    -17.70

  • ROCE

    -4.41

  • Debt/Equity

    1.11

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    45.19

  • Interest Cover

    -0.73

Analysis

all

thumbs up icon

Pros

  • ANG Lifesciences India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • ANG Lifesciences India is profitable, therefore cash runway is not a concern.
  • ANG Lifesciences India is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (38.6%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 3.3x debt.
thumbs up icon

Cons

  • Unable to evaluate ANG Lifesciences India's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate ANG Lifesciences India's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • ANG Lifesciences India's level of debt (61.2%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.
  • The average tenure for the ANG Lifesciences India board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters70.6070.6070.6070.6070.60
FII00000
DII00000
Public29.4029.4029.4029.4029.40
Government00000

Read More

Technical Analysis

RSI

70.20

MACD

0.82

50 DMA

23.52

200 DMA

28.21

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic36.2628.3923.4020.5215.5312.654.78
Fibonacci28.3925.3823.5220.5217.5115.6512.65
Camarilla20.5819.8619.1420.5217.7016.9816.26

Pivots Level: Classic

R3

+15.74

36.26

R2

+7.87

28.39

R1

+2.89

23.40

20.52
20.52
Pivot Point
LTP: 27.20

S1

-4.98

15.53

S2

-7.87

12.65

S3

-15.74

4.78

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    24.66

  • 20-EMA

    23.71

  • 30-EMA

    23.52

  • 50-EMA

    23.85

  • 100-EMA

    25.30

  • 200-EMA

    28.17

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 Feb 2026board-meetingsQuarterly Results, Half Yearly Results
14 Nov 2025board-meetingsQuarterly Results
15 Sept 2025agm
18 Sept 2024agm
05 Sept 2023agm
05 Apr 2023egm
06 Mar 2023egm
17 Oct 2022egm
20 Sept 2022agm
01 Jul 2022bonus1:4 Bonus Issue of Equity Shares14 Jul 2022

Read More

Peer Comparison

ANG Lifesciences India Ltd logo

ANG Lifesciences India Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

ANG Lifesciences India Ltd About

ANG Lifesciences India engaged in the business of manufacturing of Pharmaceuticals Products and Formulations.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2006

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.anglifesciences.com

Email icon

Email

cs@anglifesciences.com

Phone icon

Phone

91-0183-5070118/5070119

Location icon

Location

Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block, Amritsar, Punjab, 143001

Read More

ANG Lifesciences India Ltd Company History

YearHistory
2008
  • The company commenced commercial production
2010
  • The company was converted into a public limited Company on March 02, 2010
  • The company was converted into a private limited Company and the name was changed to ANG Lifesciences India Private Limited on September 22, 2010
2016
  • The company changed its name to ANG Lifesciences India Limited
  • A fresh certificate of incorporation was issued by the Registrar of Companies, Chandigarh on May 18, 2016
2021
  • The Company issued Bonus Shares in the Ratio of 1:1.
2022
  • The Company issued Bonus Shares in the Ratio of 1:4.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
CHAUHAN TRISHUL JITUSINHBuy8467381.9303 Jan 2024
CHAUHAN TRISHUL JITUSINHSell8467383.2303 Jan 2024
ALPHA LEON ENTERPRISES LLPBuy5748462112 Nov 2021
ALPHA LEON ENTERPRISES LLPSell10926677.7712 Nov 2021
WAYS VINIMAY PRIVATE LIMITEDSell32000349.5530 Sept 2021
WAYS VINIMAY PRIVATE LIMITEDSell30400370.0505 Aug 2021
WAYS VINIMAY PRIVATE LIMITEDSell51200331.2502 Aug 2021
SANJAY POPATLAL JAINBuy54400282.6428 Jul 2021
LEENA SACHIN SHETTYBuy35200183.5514 Jul 2021
SUNDEEP ARJUN KARNA HUFSell48000109.2202 Jul 2021

Read More

ANG Lifesciences India Ltd News

ANG Lifesciences confirms non-applicability of LC rules

ANG Lifesciences India Limited disclosed to BSE that it does not fall under the Large Corporate category for FY26, making SEBI borrowing requirements non-applicable to the company.

17 Apr 2026

companies

ANG Lifesciences Submits Q4 FY26 SEBI Compliance Certificate

ANG Lifesciences India Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 ended March 31, 2026, confirming proper dematerialization processes through its registrar Bigshare Services.

15 Apr 2026

companies

ANG Lifesciences clarifies price movement to BSE

ANG Lifesciences India Limited responds to BSE inquiry on recent price movement, stating no price-sensitive information exists and movement is purely market-driven.

10 Apr 2026

companies

ANG Lifesciences Reports Q3 FY26 Financial Results

ANG Lifesciences India Limited announced its Q3 FY26 unaudited financial results for the quarter ended December 31, 2025, with Board approval on February 14, 2026.

14 Feb 2026

co actions results

ANG Lifesciences Board Meet Set for Feb 14, 2026

ANG Lifesciences India Limited has scheduled its board meeting for February 14, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window closed from January 1, 2026.

05 Feb 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800